Dr. Munsoor Lateef, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Dr, Suite D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-584-4914 |
Dr. Sarath Kolluru, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Dr, Suite D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-584-4914 |
Dr. Harmeet Singh, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Rd, Suite D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-584-4914 |
Dr. Taran Kaur Singh, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Dr Ste D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-586-9363 |
News Archive
A biotech company has launched an antimicrobial surface treatment proven to kill harmful bacteria and viruses including TGEV coronavirus, the model virus for SARS COV 2, for up to twelve months after one application.
The Oregon state legislature cleared two reform bills that passed its House of Representatives earlier this week, the Portland Oregonian reports.
Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.
The Hill checks up on five health law promises from the president as implementation continues. Meanwhile, Kaiser Health News examines how some low-income people might gain insurance if their state doesn't expand its Medicaid program, but the strategy will carry risks.
Accu-Break Pharmaceuticals, Inc. announced today that it has entered into a development and license agreement with Alembic Pharmaceuticals Limited of Gujarat, India to develop new brand products that will use ABP's innovative Accu-Break tablet technologies.
› Verified 4 days ago